137 related articles for article (PubMed ID: 37655535)
1. Antigen processing and presentation-related signature-derived BNIP3 is a novel oncogene and immunotherapy determinant in osteosarcoma based on machine learning and in vitro validation.
Chen Y; Cao Y; Wu S; Cao X; Cai T; Hu H
J Gene Med; 2024 Jan; 26(1):e3586. PubMed ID: 37655535
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of immunogenic cell death indicates prognosis and tumor microenvironment infiltration in osteosarcoma.
Liu Z; Liu B; Feng C; Li C; Wang H; Zhang H; Liu P; Li Z; He S; Tu C
Front Immunol; 2022; 13():1071636. PubMed ID: 36569869
[TBL] [Abstract][Full Text] [Related]
3. By using machine learning and
Xia G; Wu S; Luo K; Cui X
Front Oncol; 2023; 13():1180191. PubMed ID: 37091161
[TBL] [Abstract][Full Text] [Related]
4. Construction of immune-related gene pairs signature to predict the overall survival of osteosarcoma patients.
Li LQ; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Khader MA; Jia-Wen ; Tao-Liu ; Li JZ
Aging (Albany NY); 2020 Nov; 12(22):22906-22926. PubMed ID: 33203792
[TBL] [Abstract][Full Text] [Related]
5. Tumor microenvironment phenotypes and prognostic evaluation tools for osteosarcoma characterized by different prognostic outcomes and immunotherapy responses.
Tu Z; Li W; Chen Z; Jiang D; Zhou S; Lv S; Cui H
J Gene Med; 2024 Jan; 26(1):e3572. PubMed ID: 37525871
[TBL] [Abstract][Full Text] [Related]
6. Auto T cells expressing chimeric antigen receptor derived from auto antibody might be a new treatment for osteosarcoma.
Weibo P; Zhaoming Y
Med Hypotheses; 2012 May; 78(5):616-8. PubMed ID: 22330890
[TBL] [Abstract][Full Text] [Related]
7. Single-cell and bulk RNA sequencing reveals Anoikis related genes to guide prognosis and immunotherapy in osteosarcoma.
Zhong C; Yang D; Zhong L; Xie W; Sun G; Jin D; Li Y
Sci Rep; 2023 Nov; 13(1):20203. PubMed ID: 37980450
[TBL] [Abstract][Full Text] [Related]
8. Necrotizing apoptosis-related genes prognosis and treatment effect analysis of osteosarcoma in children.
Chen Y; Wu L; Li Y; Zheng J; Zhong S; Gu S; Chen J
J Gene Med; 2024 Jan; 26(1):e3646. PubMed ID: 38100138
[TBL] [Abstract][Full Text] [Related]
9. A novel molecular signature for predicting prognosis and immunotherapy response in osteosarcoma based on tumor-infiltrating cell marker genes.
Tang H; Liu S; Luo X; Sun Y; Li X; Luo K; Liao S; Li F; Liang J; Zhan X; Wei Q; Liu Y; He M
Front Immunol; 2023; 14():1150588. PubMed ID: 37090691
[TBL] [Abstract][Full Text] [Related]
10. Development of an immune-related signature for predicting survival outcome and immunotherapy response in osteosarcoma.
Wang Q; Zhang W; Guo Y; Li Y; Fu K
Aging (Albany NY); 2021 Nov; 13(21):24155-24170. PubMed ID: 34747719
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance and immune landscape of a novel ferroptosis-related prognosis signature in osteosarcoma.
Yang L; Liu J; Liu S
BMC Cancer; 2023 Mar; 23(1):229. PubMed ID: 36899330
[TBL] [Abstract][Full Text] [Related]
12. Pathways of immune exclusion in metastatic osteosarcoma are associated with inferior patient outcomes.
Ligon JA; Choi W; Cojocaru G; Fu W; Hsiue EH; Oke TF; Siegel N; Fong MH; Ladle B; Pratilas CA; Morris CD; Levin A; Rhee DS; Meyer CF; Tam AJ; Blosser R; Thompson ED; Suru A; McConkey D; Housseau F; Anders R; Pardoll DM; Llosa N
J Immunother Cancer; 2021 May; 9(5):. PubMed ID: 34021032
[TBL] [Abstract][Full Text] [Related]
13. Signature based on metabolic-related gene pairs can predict overall survival of osteosarcoma patients.
Li LQ; Zhang LH; Yuan YB; Lu XC; Zhang Y; Liu YK; Wen J; Khader MA; Liu T; Li JZ; Zhang Y
Cancer Med; 2021 Jul; 10(13):4493-4509. PubMed ID: 34047495
[TBL] [Abstract][Full Text] [Related]
14. Baicalein induces human osteosarcoma cell line MG-63 apoptosis via ROS-induced BNIP3 expression.
Ye F; Wang H; Zhang L; Zou Y; Han H; Huang J
Tumour Biol; 2015 Jun; 36(6):4731-40. PubMed ID: 25618603
[TBL] [Abstract][Full Text] [Related]
15. Metastasis-related gene signature associates with immunity and predicts prognosis accurately in patients with osteosarcoma.
Qin S; Li L; Liu D
Aging (Albany NY); 2023 Jul; 15(14):7219-7236. PubMed ID: 37494671
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of circulating miR-25-3p as a novel diagnostic and prognostic biomarker in osteosarcoma.
Fujiwara T; Uotani K; Yoshida A; Morita T; Nezu Y; Kobayashi E; Yoshida A; Uehara T; Omori T; Sugiu K; Komatsubara T; Takeda K; Kunisada T; Kawamura M; Kawai A; Ochiya T; Ozaki T
Oncotarget; 2017 May; 8(20):33375-33392. PubMed ID: 28380419
[TBL] [Abstract][Full Text] [Related]
17. Specific targeting of a naturally presented osteosarcoma antigen, papillomavirus binding factor peptide, using an artificial monoclonal antibody.
Tsukahara T; Emori M; Murata K; Hirano T; Muroi N; Kyono M; Toji S; Watanabe K; Torigoe T; Kochin V; Asanuma H; Matsumiya H; Yamashita K; Himi T; Ichimiya S; Wada T; Yamashita T; Hasegawa T; Sato N
J Biol Chem; 2014 Aug; 289(32):22035-47. PubMed ID: 24962571
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
Front Immunol; 2022; 13():997765. PubMed ID: 36275664
[TBL] [Abstract][Full Text] [Related]
19. GPX8 regulates pan-apoptosis in gliomas to promote microglial migration and mediate immunotherapy responses.
Chen Z; Zheng D; Lin Z; Zhang C; Wei C; Deng X; Yan P; Zheng C; Lan C; Qin C; Wei X; Qin D; Wu Y; Peng J; Miao C; Lu L; Xia Y; Luo Q
Front Immunol; 2023; 14():1260169. PubMed ID: 37795080
[TBL] [Abstract][Full Text] [Related]
20. A Four-Pseudogene Classifier Identified by Machine Learning Serves as a Novel Prognostic Marker for Survival of Osteosarcoma.
Liu F; Xing L; Zhang X; Zhang X
Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
